P
Precision BioSciences
Durham, United States
Founded 2006 NASDAQ: DTIL
Gene Therapy Delivery Cell Therapy Nano DNA Nanotechnology Protein Engineering Nano-Bio Nanomedicine
About
ARCUS genome editing for cell therapy and gene correction
Company Details
- Type
- public
- Employees
- 200+
- Funding
- Public
Key Products
- ARCUS Nucleases
- CAR-T